Valneva and idt biologika announce collaboration for production of inactivated covid-19 vaccine vla2001

Saint- herb lain (france ) and dessau - rosslau (germany), november 29 , 2021 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, and idt biologika today announced their collaboration for the production of valneva's inactivated covid-19 vaccine candidate vla2001. this follows last week's announcement that valneva signed an advance purchase agreement with the european commission to supply up to 60 million doses of vla2001, over two years.
VALN Ratings Summary
VALN Quant Ranking